What are the best treatments for Lynch Syndrome?

Lynch Syndrome is a hereditary condition that significantly increases the risk of developing colorectal and various other cancers, primarily managed through intensive cancer surveillance and risk-reducing surgeries. Treatment is not a "cure" for the genetic mutation itself, but rather a proactive strategy involving regular screenings to detect and remove precancerous growths before they become malignant.

What are the primary clinical management strategies for Lynch Syndrome?

Because Lynch Syndrome is caused by a germline mutation in DNA mismatch repair genes, the primary clinical focus is on early detection. Management for Lynch Syndrome centers on high-frequency colonoscopies, typically starting between ages 20 and 25, or 2–5 years before the youngest affected relative was diagnosed. For patients who develop cancer, surgical intervention is often more aggressive than for the general population; for example, surgeons may recommend a subtotal colectomy to reduce the risk of secondary primary cancers in the colon.

What medications and emerging therapies are used?

While there is no medication to "fix" the genetic defect, research into chemoprevention continues. Some studies have explored the use of aspirin to reduce the risk of colorectal cancer in those with Lynch Syndrome, though this should only be done under strict physician supervision. For patients with advanced, unresectable, or metastatic cancers associated with Lynch Syndrome, immunotherapy—specifically immune checkpoint inhibitors like pembrolizumab (Keytruda)—has shown remarkable success due to the high microsatellite instability (MSI-H) often found in these tumors.

Who should be on my Lynch Syndrome care team?

Managing Lynch Syndrome requires a multidisciplinary approach to address the systemic nature of the cancer risk. Your care team should ideally include:

• Gastroenterologists: For regular surveillance colonoscopies and endoscopies.


• Genetic Counselors: To provide education on inheritance patterns and family testing.


• Oncologists: Specialists familiar with MSI-H tumor profiles and immunotherapy.


• Gynecologic Oncologists: Specifically for female patients, due to the elevated risk of endometrial and ovarian cancers.


• Clinical Psychologists: To support the emotional burden of living with a high-risk hereditary condition.

Next steps

• Consult with a board-certified genetic counselor to map your family history.


• Establish a surveillance schedule with a gastroenterologist experienced in Lynch Syndrome.


• Connect with the 79 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Discuss current clinical trials for chemoprevention or immunotherapy with your oncologist.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your healthcare team for personalized treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Lynch Syndrome.


• Orphanet: Lynch Syndrome (ORPHA:144).


• National Cancer Institute (NCI) PDQ: Genetics of Colorectal Cancer.


• Lynch Syndrome International (LSI).